Clinical Trial Update: Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC [Phase 2]

View source ↗

Summary

Phase II trial evaluating pulsed paclitaxel (Taxol) with concurrent thoracic radiotherapy and adjuvant chemotherapy in stage III non-small cell lung cancer; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Taxol (paclitaxel)

Snippet

Sponsor: Leo W. Jenkins Cancer Center | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED